Literature DB >> 34734808

Colchicine for cardiovascular therapy: A drug interaction perspective and a safety meta-analysis.

Selçuk Şen1, Eda Karahan1, Cansu Büyükulaş1, Yasin Onur Polat1, Ali Yağız Üresin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34734808      PMCID： PMC8575392          DOI： 10.5152/AnatolJCardiol.2021.707

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN： 2149-2263            Impact factor:   1.596


× No keyword cloud information.
  21 in total

1.  Effect of Colchicine on Platelet-Platelet and Platelet-Leukocyte Interactions: a Pilot Study in Healthy Subjects.

Authors:  Binita Shah; Nicole Allen; Bhisham Harchandani; Michael Pillinger; Stuart Katz; Steven P Sedlis; Christina Echagarruga; Svetlana Krasnokutsky Samuels; Pajazit Morina; Prabhjot Singh; Liza Karotkin; Jeffrey S Berger
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

Review 2.  Update on colchicine, 2017.

Authors:  Anastasia Slobodnick; Binita Shah; Svetlana Krasnokutsky; Michael H Pillinger
Journal:  Rheumatology (Oxford)       Date:  2018-01-01       Impact factor: 7.580

3.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Authors:  Paul M Ridker; Brendan M Everett; Tom Thuren; Jean G MacFadyen; William H Chang; Christie Ballantyne; Francisco Fonseca; Jose Nicolau; Wolfgang Koenig; Stefan D Anker; John J P Kastelein; Jan H Cornel; Prem Pais; Daniel Pella; Jacques Genest; Renata Cifkova; Alberto Lorenzatti; Tamas Forster; Zhanna Kobalava; Luminita Vida-Simiti; Marcus Flather; Hiroaki Shimokawa; Hisao Ogawa; Mikael Dellborg; Paulo R F Rossi; Roland P T Troquay; Peter Libby; Robert J Glynn
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

4.  Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.

Authors:  Paul M Ridker; Brendan M Everett; Aruna Pradhan; Jean G MacFadyen; Daniel H Solomon; Elaine Zaharris; Virak Mam; Ahmed Hasan; Yves Rosenberg; Erin Iturriaga; Milan Gupta; Michelle Tsigoulis; Subodh Verma; Michael Clearfield; Peter Libby; Samuel Z Goldhaber; Roger Seagle; Cyril Ofori; Mohammad Saklayen; Samuel Butman; Narendra Singh; Michel Le May; Olivier Bertrand; James Johnston; Nina P Paynter; Robert J Glynn
Journal:  N Engl J Med       Date:  2018-11-10       Impact factor: 91.245

5.  Tubulin bound to colchicine forms polymers different from microtubules.

Authors:  J M Andreu; S N Timasheff
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

Review 6.  The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.

Authors:  Gonzalo J Martínez; David S Celermajer; Sanjay Patel
Journal:  Atherosclerosis       Date:  2017-12-25       Impact factor: 5.162

Review 7.  Colchicine: 1998 update.

Authors:  E Ben-Chetrit; M Levy
Journal:  Semin Arthritis Rheum       Date:  1998-08       Impact factor: 5.532

8.  Low-dose colchicine for secondary prevention of cardiovascular disease.

Authors:  Stefan M Nidorf; John W Eikelboom; Charley A Budgeon; Peter L Thompson
Journal:  J Am Coll Cardiol       Date:  2012-12-19       Impact factor: 24.094

9.  Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: a systematic review and meta-analysis on 12 869 patients.

Authors:  Alessandro Andreis; Massimo Imazio; Francesco Piroli; Stefano Avondo; Matteo Casula; Elena Paneva; Gaetano Maria De Ferrari
Journal:  Eur J Prev Cardiol       Date:  2022-02-03       Impact factor: 7.804
View more
  1 in total

1.  Letter to the Editor Regarding "Colchicine Against SARS-CoV-2 Infection: What is the Evidence?"

Authors:  Josef Finsterer
Journal:  Rheumatol Ther       Date:  2022-06-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.